Income Statement (TTM)
Anlon Healthcare Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 03-31 |
2022 03-31 |
2023 03-31 |
2024 03-31 |
2025 03-31 |
|
|---|---|---|---|---|---|
| Revenue | 160 | 574 | 1,131 | 666 | 1,203 |
| Change (%) | 259.14 | 97.04 | -41.09 | 80.64 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 125 | 438 | 889 | 349 | 752 |
| Change (%) | 250.52 | 102.89 | -60.76 | 115.70 | |
| % of Revenue | 78.21 | 76.33 | 78.60 | 52.35 | 62.51 |
| Gross Operating Profit | 35 | 136 | 242 | 317 | 451 |
| Change (%) | 290.08 | 78.19 | 31.14 | 42.11 | |
| % of Revenue | 21.79 | 23.67 | 21.40 | 47.65 | 37.49 |
| SG&A | 32 | 33 | 43 | 62 | 66 |
| Change (%) | 3.16 | 30.42 | 46.90 | 5.47 | |
| % of Revenue | 19.77 | 5.68 | 3.76 | 9.37 | 5.47 |
| R&D | |||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 230 | 534 | 1,018 | 527 | 893 |
| Change (%) | 131.95 | 90.78 | -48.20 | 69.40 | |
| % of Revenue | 143.99 | 92.99 | 90.04 | 79.17 | 74.25 |
| Operating Income | -70 | 40 | 113 | 139 | 310 |
| Change (%) | -157.20 | 180.20 | 23.17 | 123.35 | |
| % of Revenue | -43.99 | 7.01 | 9.96 | 20.83 | 25.75 |
| Interest Expense | -32 | -41 | -38 | -41 | -38 |
| Change (%) | 29.50 | -7.72 | 7.59 | -7.53 | |
| % of Revenue | -19.84 | -7.15 | -3.35 | -6.12 | -3.13 |
| Net Income | -102 | -1 | 58 | 97 | 205 |
| Change (%) | -98.95 | -5,503.90 | 65.93 | 112.46 | |
| % of Revenue | -64.09 | -0.19 | 5.15 | 14.50 | 17.05 |
Source: Capital IQ
